417 related articles for article (PubMed ID: 3031160)
1. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
2. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
Defrance T; Aubry JP; Vanbervliet B; Banchereau J
J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
[TBL] [Abstract][Full Text] [Related]
3. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
5. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
7. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
[TBL] [Abstract][Full Text] [Related]
9. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
12. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
13. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
14. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
Ennist DL; Elkins KL; Cheng SC; Howard M
J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
[TBL] [Abstract][Full Text] [Related]
15. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
Lasky JL; Thorbecke GJ
Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
[TBL] [Abstract][Full Text] [Related]
16. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
[TBL] [Abstract][Full Text] [Related]
17. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells.
Nakagawa T; Hirano T; Nakagawa N; Yoshizaki K; Kishimoto T
J Immunol; 1985 Feb; 134(2):959-66. PubMed ID: 2981272
[TBL] [Abstract][Full Text] [Related]
19. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
[TBL] [Abstract][Full Text] [Related]
20. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
Jelinek DF; Lipsky PE
J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
